Levetiracetam versus carbamazepine in treatment of rolandic epilepsy.


Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
05 2019
Historique:
received: 01 02 2019
revised: 08 02 2019
accepted: 08 02 2019
pubmed: 19 3 2019
medline: 1 7 2020
entrez: 19 3 2019
Statut: ppublish

Résumé

The aim of the current study was to systematically review the literature to compare the efficacy of levetiracetam (LEV) with that of carbamazepine (CBZ) to control seizures and reduce the burden of interictal epileptiform discharges in children with rolandic epilepsy (RE) and also to compare their tolerability. We searched the electronic database PubMed on January 9, 2019 for original articles that included the following English-language search terms in the title: "Rolandic epilepsy" OR "benign childhood epilepsy with centrotemporal spikes" since 2000. We concentrated our review on three main areas: 1. Neuropsychological impairments in children with RE; 2. Influence of epileptic activity on cognitive performance in RE; 3. Effects of antiepileptic drug (AED) therapies in RE. The primary search yielded 308 papers. We reviewed the results and removed duplicate articles and all nonoriginal, non-English papers. Finally, after carefully reviewing the full texts, we included 44 original articles to achieve the aims of this review. Physicians taking care of children with RE should be aware of the risks for cognitive dysfunctions in these patients and screen their patients for any subtle dysfunction that may affect their academic performance and achievement. If and when the physician decides to prescribe an AED for their patients with RE, LEV is probably a better option compared with CBZ to prescribe for these children.

Identifiants

pubmed: 30884401
pii: S1525-5050(19)30114-3
doi: 10.1016/j.yebeh.2019.02.009
pii:
doi:

Substances chimiques

Anticonvulsants 0
Benzodiazepines 12794-10-4
Carbamazepine 33CM23913M
Levetiracetam 44YRR34555

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Ali A Asadi-Pooya (AA)

Neuroscience Research Center, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran; Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, PA, USA. Electronic address: aliasadipooya@yahoo.com.

Mahta Forouzesh (M)

Cobel Darou, Tehran, Iran. Electronic address: m.forouzesh@cobeldarou.com.

Hamid Eidi (H)

Cobel Darou, Tehran, Iran. Electronic address: h.eidi@cobeldarou.com.

Seyed Emad Mirzaghafour (SE)

Cobel Darou, Tehran, Iran. Electronic address: e.mirzaghafour@cobeldarou.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH